02/29/2012 - 4:06pm

The Food and Drug Administration has approved two separate dosing innovations for multiple sclerosis patients that are being treated with a Biogen Idec drug.

02/28/2012 - 5:32pm

Lowering health costs will require a greater understanding of differences between two distinct groups of patients, according to a new study, which also noted a growing availability of specialty drugs for complex and chronic conditions outside the hospital.

02/27/2012 - 12:34pm

A division of specialty pharmacy provider The Apothecary Shops has become the exclusive distributor of a drug used in glaucoma surgery, the company said.

02/24/2012 - 11:04am

Walgreens Specialty Pharmacy on Thursday released data showing that both patients and their health plans can realize savings of up to 60% on the cost of infused specialty medications by choosing alternate treatment sites.

02/23/2012 - 3:20pm

The Food and Drug Administration has given tentative approval to a division of Mylan for a generic drug for treating HIV and AIDS in children in developing countries.

02/23/2012 - 11:31am

A Northern Ireland pharmaceutical company has acquired a chemotherapy agent from Gilead.

02/23/2012 - 11:18am

The Food and Drug Administration has accepted a new drug application for the treatment of idiopathic Parkinson’s disease.

02/23/2012 - 10:54am

The Food and Drug Administration has approved a drug for a rare disorder that previously had no approved medical therapies, the agency said.

02/22/2012 - 11:08am

Novartis plans to pay up to $440 million for rights to a drug for treating hepatitis C made by Enanta Pharmaceuticals, Enanta said.